MDACC — Houston, Texas

MDACC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

MDACC has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma.

Sponsors: Sumitomo Pharma America, Inc., Agenus Inc., Vividion Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MDACC?

MDACC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MDACC conducted?

MDACC has 9 clinical trials on record, with 5 currently active. Their work covers Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma.

Is MDACC accredited by Crixeo Clinical Trials?

MDACC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MDACC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.